Isosorbide oral solution for Meniere's vertigo
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This trial tests an oral solution of isosorbide, a medication that may reduce fluid buildup in the inner ear, to see if it can prevent vertigo attacks in people with Meniere's disease. It could be an option if you have frequent, one-sided vertigo and have not had prior ear surgeries or certain injections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with Meniere's disease in one ear and have had at least 3 vertigo attacks in the last 6 months.
- You have not had ear surgery or a gentamicin injection for Meniere's disease.
- You have not taken certain medications like betahistine, strong water pills, or steroids in the last 4 weeks.
- You do not have serious heart, kidney, liver, or blood pressure problems.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study compares injections of steroid medicine into the ear versus a dummy (placebo) injection to see if it reduces vertigo attacks in people with Ménière’s disease. It may help by improving balance symptoms and reducing how often attacks happen.
This trial tests if a mild electrical current applied behind the ear can reduce dizziness and hearing problems in people with Meniere's disease. It may help those who still get vertigo attacks despite taking standard medications.
This Phase 4 study tests whether migraine-type medications can help people with active or frequent Meniere’s disease. If you have symptoms like inner-ear episodes, the trial may help find a better way to control them.
This study tests if gentle neck therapy (called cervical mobilization) can help reduce dizziness, improve balance, and help your body feel its position better. If you have Meniere’s disease and ongoing dizziness or imbalance, this treatment might add to your care routine.
This trial tests a new medication called Vespireit (prolonged-release buspirone) for people with chronic dizziness caused by a problem with the autonomic nervous system. The study aims to see if the drug helps reduce dizziness and improve quality of life.
This trial uses an advanced MRI (7 Tesla) to look at a specific inner-ear swelling pattern in people with recent, one-sided Meniere’s disease symptoms. It may help confirm the diagnosis and improve how clinicians evaluate your inner-ear condition.
Hear when a new Meniere´s Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.